TNFRSF17 and neoplasm: In vitro study also reported that the anti-tumor activity persisted even in the presence of high concentration of sBCMA because the antibody component of MEDI2228 possessed strong binding to membrane-bound BCMA but weak affinity to monomeric human BCMA [92].